The Effect of Prior Comparison MRI on Interpretive Performance of Screening Breast MRI
- 3 January 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 2 (1) , 36-42
Abstract
To evaluate the effect of prior comparison MRI on interpretive performance of screening breast MRI. After institutional review board approval, all screening breast MRI examinations performed from January 2011 through December 2014 were retrospectively reviewed. Screening performance metrics were estimated and compared for exams with and without a prior comparison MRI, using logistic regression models to adjust for age and screening indication (BRCA mutation or thoracic radiation versus breast cancer history versus high-risk lesion history versus breast cancer family history). Most exams, 4509 (87%), had a prior comparison MRI (incidence round), while 661 (13%) did not (prevalence round). Abnormal interpretation rate (6% vs 20%, P < 0.01), biopsy rate (3% vs 9%, P < 0.01), and false-positive biopsy recommendation rate per 1000 exams (21 vs 71, P < 0.01) were significantly lower in the incidence rounds compared to the prevalence rounds, while specificity was significantly higher (95% vs 81%, P < 0.01). There was no difference in cancer detection rate (CDR) per 1000 exams (12 vs 20, P = 0.1), positive predictive value of biopsies performed (PPV3) (35% vs 23%, P = 0.1), or sensitivity (86% vs 76%, P = 0.4). Presence of a prior comparison significantly improves incidence round screening breast MRI examination performance compared with prevalence round screening. Consideration should be given to updating the BI-RADS breast MRI screening benchmarks and auditing prevalence and incidence round examinations separately.Keywords
This publication has 18 references indexed in Scilit:
- Auditing a Breast MRI Practice: Performance Measures for Screening and Diagnostic Breast MRIJournal of the American College of Radiology, 2014
- Five‐year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancerJournal of Medical Imaging and Radiation Oncology, 2013
- Multimodality Breast Cancer Screening in Women with a Familial or Genetic PredispositionCurrent Oncology, 2010
- Multicenter Comparative Multimodality Surveillance of Women at Genetic-Familial High Risk for Breast Cancer (HIBCRIT Study): Interim ResultsRadiology, 2007
- American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to MammographyCA: A Cancer Journal for Clinicians, 2007
- Importance of Comparison of Current and Prior Mammograms in Breast Cancer ScreeningRadiology, 2007
- Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast CancerJournal of Clinical Oncology, 2005
- Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)The Lancet, 2005
- Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast ExaminationJAMA, 2004
- Differential Value of Comparison with Previous Examinations in Diagnostic Versus Screening MammographyAmerican Journal of Roentgenology, 2002